The effect of meloxicam and cryopreserved placenta extract on initial inflammatory response - an experimental study

Area of Science:

• Pharmacology
• Inflammation Research
• Tissue Regeneration

Background:

• Inflammation's alterative phase causes tissue damage, necessitating early suppression for effective therapy.
• Combining nonsteroidal anti-inflammatory drugs with pleiotropic agents may enhance anti-inflammatory effects.

Purpose of the Study:

• To evaluate the combined effect of cryopreserved placenta extract and meloxicam on the alterative phase of inflammation.
• To assess the efficacy of this combination therapy in a rat model of aseptic skin and subcutaneous tissue inflammation.

Main Methods:

• Induction of aseptic inflammation in rats using subcutaneous acetic acid and dextran.
• Administration of meloxicam, cryopreserved placenta extract, or their combination.
• Measurement of necrotic ulcer area as an indicator of the antialterative effect.

Main Results:

• Combined meloxicam and placenta extract reduced necrotic ulcer area by 23.9% on day 7 (p < 0.05).
• On day 27, the combined therapy showed a 1.7-fold greater antialterative effect than meloxicam alone.
• The combination was also 1.2 times more effective than placenta extract monotherapy.

Conclusions:

• Combined use of meloxicam and cryopreserved placenta extract demonstrates significant antialterative effects.
• This combination therapy shows superior efficacy in mitigating inflammation-induced tissue damage compared to monotherapy.
• The findings support the potential of this combined approach for managing inflammatory processes.